---
schema_version: "secwatch.filing_event.v1"
accession: "0001051514-23-000022"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2023-06-30T23:59:59+00:00"
generated_at: "2026-06-13T13:38:12.448399+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "medium"
source: SEC EDGAR
---

# STRATA Skin Sciences receives NASDAQ bid price deficiency notice; appoints Dr. Uri Geiger as Chairman

## Summary
- Received NASDAQ notice on June 29, 2023 for bid price below $1.00 for 30 consecutive business days.
- Has 180 days (until Dec 26, 2023) to regain compliance by closing at $1.00+ for 10 consecutive trading days.
- Dr. Uri Geiger appointed Chairman effective July 3, 2023; William Humphries steps down but remains on Board.
- Humphries transition due to becoming CEO of Alcami; Geiger has 20+ years medtech experience.

## SEC filing metadata
- accession: 0001051514-23-000022
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2023-06-30T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: medium
- sec_items: 3.01, 7.01, 8.01, 9.01, 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000105151423000022/0001051514-23-000022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000105151423000022/form_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001051514-23-000022
- JSON: https://secwatch.observer/filing/0001051514-23-000022.json
- Plain text: https://secwatch.observer/filing/0001051514-23-000022.txt

## Key facts
- Listing & Compliance Notices
  STRATA Skin Sciences, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: June 29, 2023, STRATA Skin Sciences, Inc. (the "Company") received written notification (the "Notice") from The NASDAQ Stock Market ("NASDAQ") that the closing bid price of its common stock had been below the minimum $1.00 per share for the previous 30 consecutive business days, and that the Company is therefore not in compliance with the requirements for continued listing on the NASDAQ Capital Market under NASDAQ Listing Rule 5550(a)(2). The Notice provides the Company with an initial period of 180 calendar days, or until December 26, 2023, to regain compliance with the listing rules. The C
  evidence_url: https://www.sec.gov/Archives/edgar/data/1051514/000105151423000022/0001051514-23-000022-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.